FDA Set To Cut Off 17,000 Women Annually From Lifesaving Drug
From the diaries by lexington_concord… Obama’s Food and Drug Administration (FDA) is due to take up the case of Avastin, a cancer drug that successfully treats some 17,000 women annually. With a coming December 17 decision, the FDA seems poised to take this drug away from these patients quite despite the fact that their doctors find the drug effective. The most dangerous period of time | Read More »
Avastin Sticker Shock
Avastin is a cancer drug developed by Roche Holding AG. It is also a costly drug. Avastin is used successfully for certain types of cancer (colorectal, lung, kidney, brain, and breast). It’s that last one that is raising eyebrows.
Obamacare created a new Independent Medicare Advisory Board (IMAB) to ‘curtail spending’. Now, on advice from the IMAB, the FDA is considering restricting Avastin. It is amazing to see the range of responses from the left here in America.
Read More →
Read More »
Obamacare worth 17.5K dead women a year?
If you’ve missed the Avastin controversy, here’s a quick summary of it: Avastin is a general anti-cancer drug that got fast-tracked by the FDA a few years ago and is now prescribed to under 18 thousand women a year in the United States who suffer from the last stages of breast cancer. It doesn’t cure the cancer; it has side effects; and its beneficial effects | Read More »